Lv71
4990 积分 2022-08-15 加入
BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
3小时前
求助中
BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
3小时前
已关闭
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1天前
待确认
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1
9天前
已关闭
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression
1个月前
已关闭
Lisaftoclax: First Approval
1个月前
已完结
Antigens in membranous nephropathy: discovery and clinical implications
2个月前
已完结
Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study
2个月前
已完结
Tyrosine kinase inhibitor treatment patterns in patients with chronic-phase chronic myeloid leukemia: a single center data from China
2个月前
已完结
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Can Be Treated with Chemotherapy-Free Regimens without Transplant
2个月前
已完结
皖公网安备34019202002308
